| Libre Del Cigarrillo: Development of an mHealth Smoking Cessation App to Extend Reach of a Validated Smoking Cessation Intervention for Spanish-speaking Smokers (NCT07754448) | H. Lee Moffitt Cancer Center and Research Institute | 2026-08-01 |
| Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors (NCT07487168) | H. Lee Moffitt Cancer Center and Research Institute | 2026-08-01 |
| PRehabilitation Intervention to Modify Eating for Breast Cancer Patients (PRIME) (NCT07638150) | H. Lee Moffitt Cancer Center and Research Institute | 2026-08-01 |
| Trial of Therapies With IT cDC1s Combined w/ IT Trastuzamab for Her+ or IT Nivolumab for Her- BC LMD (NCT07694986) | H. Lee Moffitt Cancer Center and Research Institute | 2026-08-01 |
| Development of a Mindfulness-Based Smartphone Application for BMT Caregivers (NCT07352943) | H. Lee Moffitt Cancer Center and Research Institute | 2026-08-01 |
| Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma (NCT07725380) | H. Lee Moffitt Cancer Center and Research Institute | 2026-07-15 |
| Modifying Diet to Improve Gut Microbiome (NCT03924778) | H. Lee Moffitt Cancer Center and Research Institute | 2026-07-01 |
| Evaluation and Outcomes of SAVI Scout MD for Localized Breast Surgery (NCT07686250) | H. Lee Moffitt Cancer Center and Research Institute | 2026-07-01 |
| Testing an MBI for Smoking Cessation and Alcohol Use Among Cancer Survivors (NCT07447635) | H. Lee Moffitt Cancer Center and Research Institute | 2026-05-15 |
| Wet Heparinized Suction for Abdominal Cancer (NCT05041335) | H. Lee Moffitt Cancer Center and Research Institute | 2026-03-15 |
| Phase 2a Study of High-Dose Testosterone Followed by Radioligand Therapy in mCRPC (NCT07476001) | H. Lee Moffitt Cancer Center and Research Institute | 2026-03-03 |
| Compare Airway Pressure Release Ventilation (APRV) to Conventional Mechanical Ventila (NCT07111039) | H. Lee Moffitt Cancer Center and Research Institute | 2026-03-01 |
| Intermittent Fasting for Pancreatitis (NCT04760847) | H. Lee Moffitt Cancer Center and Research Institute | 2026-03-01 |
| Phase III Trial of Brain MRI Surveillance in Stage IV Breast Cancer (NCT07357298) | H. Lee Moffitt Cancer Center and Research Institute | 2026-02-25 |
| Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes (NCT07194044) | H. Lee Moffitt Cancer Center and Research Institute | 2026-02-05 |
| Asciminib Maintenance Therapy Following alloHCT or CAR T to Prevent Relapse in Adults With Ph+ALL (NCT07250087) | H. Lee Moffitt Cancer Center and Research Institute | 2026-01-21 |
| Digoxin Medulloblastoma Study (NCT06701812) | H. Lee Moffitt Cancer Center and Research Institute | 2026-01-15 |
| Phase 2 Combination of Melphalan/HDS Via PHP + Tebentafusp in Treating Metastatic Uveal Melanoma (NCT07276386) | H. Lee Moffitt Cancer Center and Research Institute | 2025-12-31 |
| Clinical Trial of CD40L-augmented TIL for Patients With Advanced Melanoma (NCT06961357) | H. Lee Moffitt Cancer Center and Research Institute | 2025-12-03 |
| Hybrid Effectiveness-Implementation Trial to Integrate Precision Skin Cancer Risk Feedback in FQHCs (NCT07222995) | H. Lee Moffitt Cancer Center and Research Institute | 2025-10-10 |
| A First-in-Human Study of FID-022 in Solid Tumor Patients (NCT07249775) | H. Lee Moffitt Cancer Center and Research Institute | 2025-10-08 |
| Ropeginterferon in Patients w/Cutaneous T-Cell Lymphoma (CTCL) (NCT07047885) | H. Lee Moffitt Cancer Center and Research Institute | 2025-08-27 |
| Predictors of Health-Related QOL in Adults With CLL or Small Lymphocytic Lymphoma (NCT07030400) | H. Lee Moffitt Cancer Center and Research Institute | 2025-07-17 |
| The MIND-BC Study: MIND Diet for Breast Cancer Cognition (NCT07018986) | H. Lee Moffitt Cancer Center and Research Institute | 2025-07-09 |
| Study Investigating Intravesical HDAC Inhibition to Improve Response to Immuno-Oncology Agents (NCT06963346) | H. Lee Moffitt Cancer Center and Research Institute | 2025-06-24 |
| Pembrolizumab for Advanced Cutaneous Sarcomas Not Including Angiosarcoma (NCT07007273) | H. Lee Moffitt Cancer Center and Research Institute | 2025-06-20 |
| Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/ NSCLC (NCT06745882) | H. Lee Moffitt Cancer Center and Research Institute | 2025-06-13 |
| Tumor Infiltrating Lymphocyte Therapy for Pediatric High Risk Solid Tumors (NCT06047977) | H. Lee Moffitt Cancer Center and Research Institute | 2025-06-02 |
| Elranatamab Post Cilta-cel in Patients With Clinical High Risk Relapsed Myeloma (NCT06947083) | H. Lee Moffitt Cancer Center and Research Institute | 2025-05-27 |
| ProSalud in Latinos Living in Rural/Agricultural Communities Within Moffitt's Catchment Area (NCT07218848) | H. Lee Moffitt Cancer Center and Research Institute | 2025-05-22 |
| NutritiOUs fRuIts and veggieS to Improve Health: A Culinary Medicine Intervention (NCT06926972) | H. Lee Moffitt Cancer Center and Research Institute | 2025-04-04 |
| Ph II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCC (NCT06553885) | H. Lee Moffitt Cancer Center and Research Institute | 2025-04-01 |
| Creation of an Infrastructure to Support Delivery of mHealth Interventions for Cancer Patients (NCT06909357) | H. Lee Moffitt Cancer Center and Research Institute | 2025-03-28 |
| Tafasitamab and Lenalidomide as First Salvage Therapy for Residual Large B Cell Lym (NCT06760156) | H. Lee Moffitt Cancer Center and Research Institute | 2025-03-19 |
| Phase II Study of Neoadjuvant Cetuximab and Cemiplimab in Patients Undergoing Surgery for HNSCC (NCT06855212) | H. Lee Moffitt Cancer Center and Research Institute | 2025-02-26 |
| Study of Adaptive Immunotherapy With VEGFR-TKI in Patients With Advanced RCC (NCT06860386) | H. Lee Moffitt Cancer Center and Research Institute | 2025-02-25 |
| Phase II Study of Systemic Screening in Pathologic Node Positive Breast Cancer (NCT06833502) | H. Lee Moffitt Cancer Center and Research Institute | 2025-02-24 |
| Physical Activity and Nutrition to Halt Elevated Risk in the Pancreas Interception Center (NCT06712797) | H. Lee Moffitt Cancer Center and Research Institute | 2025-02-19 |
| Adaptive Androgen Deprivation and Docetaxel in Metastatic Castration Sensitive Prostate Cancer (NCT06734130) | H. Lee Moffitt Cancer Center and Research Institute | 2025-01-10 |
| Ruxolitinib vs Prednisone as First-line Therapy for cGVHD Needing Systemic Therapy (NCT06660355) | H. Lee Moffitt Cancer Center and Research Institute | 2024-12-23 |
| Sacituzumab Govitecan and Zimberelimab w/SRS in the Management of Metastatic Triple Negative Breast Cancer With Brain Metastases (NCT06238921) | H. Lee Moffitt Cancer Center and Research Institute | 2024-12-19 |
| BCL2i CLAG-M in R/R Acute Myeloid Leukemia (NCT06660368) | H. Lee Moffitt Cancer Center and Research Institute | 2024-11-26 |
| Discontinuation of Hypomethylating Agent and Venetoclax in Patients With AML MRD (NCT06511882) | H. Lee Moffitt Cancer Center and Research Institute | 2024-11-07 |
| Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma (NCT06121180) | H. Lee Moffitt Cancer Center and Research Institute | 2024-11-04 |
| Immunologic Targeting of ESR1 Receptor for Hormone Receptor Expressing Metastatic Breast Cancer (NCT06691035) | H. Lee Moffitt Cancer Center and Research Institute | 2024-11-04 |
| Autologous Gamma Delta T Cells to Target Prostate Stem Cell Antigen in mCRPC (NCT06193486) | H. Lee Moffitt Cancer Center and Research Institute | 2024-10-26 |
| Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening (NCT06745895) | H. Lee Moffitt Cancer Center and Research Institute | 2024-10-21 |
| A Phase II Study of ACR-368 and Low Dose Gemcitabine in R/M HNSCC (NCT06597565) | H. Lee Moffitt Cancer Center and Research Institute | 2024-09-25 |
| Working Through Outreach, Navigation and Digital Enabled Referral and Recruitment Strategies (ACT WONDER²S) (NCT06560398) | H. Lee Moffitt Cancer Center and Research Institute | 2024-09-18 |
| Phase 2 Open Label Randomized Study of Pirtobrutinib and Brexucabtagene Autoleucel in R/R MCL (NCT06553872) | H. Lee Moffitt Cancer Center and Research Institute | 2024-08-23 |
| Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer (NCT06409390) | H. Lee Moffitt Cancer Center and Research Institute | 2024-08-14 |
| Targeting ODC as an Immunotherapeutic Target in STK11 (LKB1) Pathway-Deficient NSCLC (DFMO) (NCT06219174) | H. Lee Moffitt Cancer Center and Research Institute | 2024-08-07 |
| Support Through Remote Observation and Nutrition Guidance Program for Individuals With Gastroesophageal Cancer (NCT06497569) | H. Lee Moffitt Cancer Center and Research Institute | 2024-07-26 |
| Study to Assess Xevinapant in Preoperative Subjects With Recurrent High-Grade Glioma (rHGG) (NCT06463184) | H. Lee Moffitt Cancer Center and Research Institute | 2024-07-22 |
| Study of IPMN Progression Prevention With Tocotrienol (SIPP-T3) (NCT06519097) | H. Lee Moffitt Cancer Center and Research Institute | 2024-07-09 |
| Mindfulness-Based Ecological Momentary Intervention For Smoking Cessation Among Cancer Survivors (NCT06476548) | H. Lee Moffitt Cancer Center and Research Institute | 2024-06-12 |
| Personalized Dendritic Cell Vaccine Pilot for High Risk TNBC After Neoadjuvant Therapy (NCT06435351) | H. Lee Moffitt Cancer Center and Research Institute | 2024-06-12 |
| App for Reducing Cravings to Smoke (NCT06088498) | H. Lee Moffitt Cancer Center and Research Institute | 2024-06-11 |
| Exercise Prehabilitation for Locoregional Esophageal Cancer (NCT06430346) | H. Lee Moffitt Cancer Center and Research Institute | 2024-05-21 |
| Neoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma (NCT06295159) | H. Lee Moffitt Cancer Center and Research Institute | 2024-05-17 |
| Generating Novel Translational and Therapeutic Strategies Based on a Multicenter, Pediatric and AYA Evolutionary Tumor Board (pedsETB) (NCT06423950) | H. Lee Moffitt Cancer Center and Research Institute | 2024-05-01 |
| Rituximab and Zanubrutinib in Patients With Indolent B-cell Lymphomas (NCT06350318) | H. Lee Moffitt Cancer Center and Research Institute | 2024-04-19 |
| Irreversible Electroporation & Pembro Immunotherapy in Locally Advanced Pancreatic Cancer (NCT06378047) | H. Lee Moffitt Cancer Center and Research Institute | 2024-04-10 |
| High-Fermented Food Intervention Among Locally Advanced Rectal Cancer Patients (The FEED Trial) (NCT06337552) | H. Lee Moffitt Cancer Center and Research Institute | 2024-04-04 |
| Cancer Coaching and Remote Education for Self-Empowerment (CARES) Study (NCT06323291) | H. Lee Moffitt Cancer Center and Research Institute | 2024-04-01 |
| TBio-4101 and Pembro wi/ or w/o Chemo in Recurrent/Metastatic HNSCC (NCT06236425) | H. Lee Moffitt Cancer Center and Research Institute | 2024-03-14 |
| Avapritinib With Decitabine in Patients With SM-AHN (NCT06327685) | H. Lee Moffitt Cancer Center and Research Institute | 2024-03-13 |
| Study of CG0070 After Transurethral Resection in Patients With IR NMIBC (NCT06253845) | H. Lee Moffitt Cancer Center and Research Institute | 2024-03-01 |
| Remote Exercise and Nutritional Prehabilitation for Pancreatic Cancer (NCT06423963) | H. Lee Moffitt Cancer Center and Research Institute | 2024-02-09 |
| Investigation of MP Pollution in the Human Respiratory System and Its Relationship to Lung Cancer (NCT06530615) | H. Lee Moffitt Cancer Center and Research Institute | 2024-02-05 |
| Biomarker Approach to Screening for the Early Detection of HPV-related Oropharyngeal Cancer (BASH OPC) (NCT06305676) | H. Lee Moffitt Cancer Center and Research Institute | 2024-01-22 |
| Breast Cancer Survivors RESET (Reducing Weight and Elevated Stress Levels Using Educational and Behavioral Tools): A Pilot, Feasibility Study (NCT07101861) | H. Lee Moffitt Cancer Center and Research Institute | 2024-01-20 |
| Phototherapy and Mogamulizumab in Early Stage MF (PLIGHT) (NCT06235281) | H. Lee Moffitt Cancer Center and Research Institute | 2024-01-18 |
| Neratinib In Combination With Chemotherapy/Trastuzumab/Pembrolizumab In HER2 Gastroesophageal Cancer (NCT06109467) | H. Lee Moffitt Cancer Center and Research Institute | 2024-01-12 |
| Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL) (NCT06144606) | H. Lee Moffitt Cancer Center and Research Institute | 2023-12-26 |
| Phase 2 Trial of Adaptive Radiotherapy Boost for HNSCC (NCT06137274) | H. Lee Moffitt Cancer Center and Research Institute | 2023-12-14 |
| REFLECT: Reproductive Education and Fertility Links for Cancer Treatment (NCT06199726) | H. Lee Moffitt Cancer Center and Research Institute | 2023-12-11 |
| Non-Invasive Biomarkers in Prostate Cancer Disease Management (NCT06144619) | H. Lee Moffitt Cancer Center and Research Institute | 2023-11-21 |
| Single-Arm Comprehensive Ablative Bridging Irradiation I Prior to CD19 CAR-T In High-Risk R/R LBCL (NCT06104592) | H. Lee Moffitt Cancer Center and Research Institute | 2023-11-08 |
| Aim 1: App for Reducing Cravings to Smoke (NCT06923033) | H. Lee Moffitt Cancer Center and Research Institute | 2023-10-09 |
| The MONITOR Study: Remote Monitoring Of a Nutrition Intervention To Optimize Treatment Response (NCT06050395) | H. Lee Moffitt Cancer Center and Research Institute | 2023-09-12 |
| Enhancing Cancer Survivorship With Pickleball (NCT06048822) | H. Lee Moffitt Cancer Center and Research Institute | 2023-09-11 |
| A First in Human Dose Escalation of Dendritic Cell Vaccine (DCV) (NCT05809752) | H. Lee Moffitt Cancer Center and Research Institute | 2023-08-22 |
| Support Through Remote Observation and Nutrition Guidance Program (STRONG-PCS) (NCT06001268) | H. Lee Moffitt Cancer Center and Research Institute | 2023-08-14 |
| Intravesical Adoptive Cell Therapy w/ TIL for BCG Exposed High Grade NMIBC (NCT05768347) | H. Lee Moffitt Cancer Center and Research Institute | 2023-08-10 |
| Senior Adult Hepatobiliary Prehab Study (NCT05921552) | H. Lee Moffitt Cancer Center and Research Institute | 2023-06-26 |
| Pilot Study of Nivolumab w/Ipilimumab or Relatlimab in Surgically Resectable Melanoma Brain Metastases (NCT05704933) | H. Lee Moffitt Cancer Center and Research Institute | 2023-06-06 |
| Genomically Guided Radiation Dose Personalization in Locally Advanced NSCLC (NCT05873439) | H. Lee Moffitt Cancer Center and Research Institute | 2023-05-25 |
| Itacitinib Pre-modulation in DLBCL Receiving CAR T Cell Therapy (NCT05757219) | H. Lee Moffitt Cancer Center and Research Institute | 2023-05-19 |
| CalPeg for Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) (NCT05581030) | H. Lee Moffitt Cancer Center and Research Institute | 2023-05-01 |
| The ENHANCE Study: Exercise and Nutrition in Head And Neck CancEr Survivors (NCT05798780) | H. Lee Moffitt Cancer Center and Research Institute | 2023-04-06 |
| Adaptive Therapy of Vismodegib in Advanced Basal Cell Carcinoma (NCT05651828) | H. Lee Moffitt Cancer Center and Research Institute | 2023-03-23 |
| Outreach Core Activities (NCT05832177) | H. Lee Moffitt Cancer Center and Research Institute | 2023-03-22 |
| Clinical Trial of CD40L-Augmented TIL for Patients With EGFR, ALK, ROS1 or HER2-Driven NSCLC (NCT05681780) | H. Lee Moffitt Cancer Center and Research Institute | 2023-03-10 |
| Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority Populations (NCT05687188) | H. Lee Moffitt Cancer Center and Research Institute | 2023-02-22 |
| Luspatercept for Anemia in Lower Risk MDS or Non-proliferative MDS/MPN Neoplasms (NCT05732961) | H. Lee Moffitt Cancer Center and Research Institute | 2023-02-21 |
| Exercise Prehabilitation Among Older Patients With Hematological Malignancies Preparing For CAR-T Cell Immunotherapy (NCT05763563) | H. Lee Moffitt Cancer Center and Research Institute | 2023-02-21 |
| Remote Resistance Exercise Powering Survivors - Gastrointestinal Oncology (NCT05664178) | H. Lee Moffitt Cancer Center and Research Institute | 2023-02-20 |
| CPX-351 in Combination With Gemtuzumab Ozogamicin in Newly Diagnosed AML (NCT05558124) | H. Lee Moffitt Cancer Center and Research Institute | 2023-02-16 |
| Siltuximab in Large Granular Lymphocytic Leukemia (LGLL) (NCT05316116) | H. Lee Moffitt Cancer Center and Research Institute | 2023-02-15 |